Treatment-resistant schizophrenia

TRS - The Stubborn Psychosis

• Definition: Failure to respond to at least 2 different antipsychotic trials of adequate dose and duration (e.g., 6 weeks).
• Management Gold Standard: Clozapine is the treatment of choice.
  • Requires strict monitoring (REMS program) for agranulocytosis.
  • Baseline Absolute Neutrophil Count (ANC) must be ≥1500/µL.

⭐ Exam Favorite: Clozapine is the only antipsychotic medication demonstrated to reduce the risk of suicide.

Clozapine - The Gold Standard

• Indicated for Treatment-Resistant Schizophrenia (TRS) after failure of ≥2 other antipsychotic trials.
• Unique mechanism: high affinity for D₄ and 5-HT₂ₐ receptors, with lower D₂ affinity, reducing Extrapyramidal Symptoms (EPS).
• Superior efficacy for both positive & negative symptoms.

⭐ The only antipsychotic proven to reduce the risk of suicide in patients with schizophrenia.

• ⚠️ Major Adverse Effects:
  • Agranulocytosis: Potentially fatal ↓ in Absolute Neutrophil Count (ANC). Requires strict monitoring.
  • Myocarditis/Cardiomyopathy: High index of suspicion needed for flu-like symptoms, chest pain.
  • Metabolic Syndrome: Significant ↑ weight, lipids, and glucose.
  • Seizures: Dose-dependent risk.
  • Sialorrhea (hypersalivation).

Beyond Clozapine - Backup Plans

• Augmentation (Partial Response):

  • Electroconvulsive Therapy (ECT): Most effective augmentation for TRS, especially for positive symptoms & catatonia.
  • Lamotrigine: Can be considered; may target cognitive/negative symptoms.
  • Antidepressants (SSRIs): Add-on for comorbid depression/anxiety.

• Alternative Approaches (Intolerance/Failure):

  • High-Dose Olanzapine: Use with caution; monitor metabolic effects.
  • Antipsychotic Combinations: e.g., clozapine + aripiprazole. Increased side-effect risk.

⭐ ECT is the most evidence-backed augmentation for clozapine-resistant schizophrenia. It is particularly effective for severe, persistent positive symptoms.

High‑Yield Points - ⚡ Biggest Takeaways

• Treatment-resistant schizophrenia (TRS) is diagnosed after failure of ≥2 adequate antipsychotic trials.
• Clozapine is the gold-standard treatment for TRS and is uniquely effective in reducing suicide risk.
• Mandatory weekly-to-monthly ANC monitoring is required due to the risk of agranulocytosis.
• Be vigilant for other serious side effects like myocarditis, seizures, and metabolic syndrome.
• Electroconvulsive therapy (ECT) is the main alternative if clozapine fails or is not tolerated.
• Rule out pseudo-resistance caused by medication non-adherence or active substance use.